Q2 EPS Forecast for Corcept Therapeutics Reduced by Analyst
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for Corcept Therapeutics in a report issued on Monday, May 26th. Zacks Research analyst K. Das now expects that the biotechnology company will post earnings of $0.23 per share for the quarter, down from […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for Corcept Therapeutics in a report issued on Monday, May 26th. Zacks Research analyst K. Das now expects that the biotechnology company will post earnings of $0.23 per share for the quarter, down from […]
